Renal Protective Effect of Candesartan Cilexetil in Spontaneously Hypercholesterolemic Rats
スポンサーリンク
概要
- 論文の詳細を見る
Spontaneously hypercholesterolemic (SHC) rats exhibit hypercholesterolemia, proteinuria and focal glomerulosclerosis with age, and they finally die as a result of renal failure. In this study, the renoprotective effects of candesartan cilexetil, an angiotensin II type 1 receptor antagonist, and enalapril, an angiotensin I converting enzyme inhibitor, were examined in SHC rats. Candesartan cilexetil (0.1 and 1 mg/kg) and enalapril (10 mg/kg) were administered orally to 10-week-old SHC rats for a 6-week period. Candesartan cilexetil (1 mg/kg) and enalapril (10 mg/kg) significantly inhibited proteinuria and hypercholesterolemia to a similar extent. In untreated 16-week-old SHC rats, glomerulosclerosis, basophilic change, cast formation and interstitial mononuclear cell infiltration were observed. Candesartan cilexetil (1 mg/kg) inhibited all of these histological changes. Enalapril inhibited glomerulosclerosis and cast formation. These results show that candesartan cilexetil and enalapril have renal protective effects in SHC rats. Thus, angiotensin II might play an important role in renal pathogenesis in a model of focal glomerulosclerosis with hypercholesterolemia.
- 社団法人 日本薬理学会の論文
- 2002-03-01
著者
-
Sugiyama Yasuo
Pharmacology Research Laboratories Ii Pharmaceutical Research Division
-
Ohta M
Research Management Department Takeda Chemical Industries Ltd
-
Ohta Masayuki
Research Management Department Takeda Chemical Industries Ltd
-
Imura Yoshimi
Drug Safety Research Laboratories Pharmaceutical Research Division
-
MATSUO Takanori
Pharmacology Research Laboratories II, Pharmaceutical Research Division
-
ISHIKAWA Eiichiro
Pharmacology Research Laboratories II, Pharmaceutical Research Division
-
SHIBOUTA Yumiko
Research Management Department, Takeda Chemical Industries Ltd
-
ISHIMURA Yoshimasa
Drug Safety Research Laboratories, Pharmaceutical Research Division
-
IMURA Yoshimi
Pharmacology Research Laboratories II, Pharmaceutical Research Division
-
Shibouta Yumiko
Research Management Department Takeda Chemical Industries Ltd
-
Matsuo Takanori
Pharmacology Research Laboratories Ii Pharmaceutical Research Division
-
Ishikawa Eiichiro
Pharmacology Research Laboratories Ii Pharmaceutical Research Division
-
Ishimura Yoshimasa
Drug Safety Research Laboratories Takeda Chemical Industries Ltd.
-
Matsuo Takanori
Pharmacology Research Laboratories II
関連論文
- Basic Avoidance of Food Competition among Ruminants, Non-Ruminants and Humans -A Simple Analytic Description-
- Basic Dividing of Foods between Ruminants and Humans when based on the Production of Forages or Grain Crops,or Both -A Simple Analytic Description-
- Contrastive or Interconvertible Relationships between Forage and Ruminant Growth Analysis Equations-A Simple Description using a Symmetry-like Characteristic-
- Estimation of Light Intercepting Performance of Plant Canopy using Mean Leaf Area Weighted with Relative Light Intensity
- Renal Protective Effect of Candesartan Cilexetil in Spontaneously Hypercholesterolemic Rats
- Involvement of Angiotensin II in Progression of Renal Injury in Rats With Genetic Non-insulin-Dependent Diabetes Mellitus (Wistar Fatty Rats)
- Blockade of renin-angiotensin system ameliorates renal injury in NIDDM model rats
- "P-67 Mechanism for the Anemia Induced by Gentamicin in Rats.